CLINICAL_TRIALS
trial_result
· 2025-08-26
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity [Phase 1]
Summary
Phase 1 pediatric obesity trial of tirzepatide has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Obesity | Phase 1 | Status: COMPLETED | Results posted: 2025-08-26